tradingkey.logo

Caribou Biosciences Announces Strategic Pipeline Prioritization with Focus on CB-010 and CB-011 Oncology Programs

ReutersApr 24, 2025 9:53 PM

- Caribou Biosciences Inc CRBU.O:

  • CARIBOU BIOSCIENCES ANNOUNCES STRATEGIC PIPELINE PRIORITIZATION WITH FOCUS ON CB-010 AND CB-011 ONCOLOGY PROGRAMS

  • CARIBOU BIOSCIENCES INC - TO REDUCE WORKFORCE BY 32%

  • CARIBOU BIOSCIENCES INC - DISCONTINUES GALLOP PHASE 1 TRIAL OF CB-010 FOR LUPUS

  • CARIBOU BIOSCIENCES INC - DISCONTINUES AMPLIFY PHASE 1 TRIAL OF CB-012 FOR AML

  • CARIBOU BIOSCIENCES INC - CHANGES EXPECTED TO EXTEND CASH RUNWAY INTO H2 2027

  • CARIBOU BIOSCIENCES INC - TO PRESENT DATA FROM CB-010 AND CB-011 IN H2 2025

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI